The companies up for grabs include Kazakh Ajanta Pharma, Kyrgyz Ajanta Pharma, Surkhan Ajanta Pharma and Tajik Ajanta Pharma (an associate company). While Ajanta holds 87.5 per cent in Kazakh Ajanta Pharma, it holds 51 per cent and 52 per cent respectively in Surkhan Ajanta and Kyrgyz Ajanta. Purshottam Agarwal, managing director, said,